Skip to content

From the American College of Rheumatology

Rheumatology for Primary Care
  • Symptoms
  • Diseases
    • ANCA-Associated Vasculitis
    • Behcet’s Syndrome
    • Chronic Recurrent Multifocal Osteomyelitis
    • Crystalline Arthropathies
    • Drug or Medication-induced Rheumatic Diseases
    • Giant Cell Arteritis
    • Henoch-Schönlein Purpura (HSP)
    • IgG4-Related Disease
    • Juvenile Dermatomyositis
    • Juvenile Idiopathic Arthritis
    • Kawasaki Disease
    • Mixed Connective Tissue Disease (MCTD)
    • Multisystem Inflammatory Syndrome in Children (MIS-C)
    • Myositis
    • Polyarteritis Nodosa
    • Polymyalgia Rheumatica
    • Rheumatoid Arthritis (RA)
    • Sarcoidosis
    • Sicca/Sjogren’s Disease
    • Spondyloarthritis
    • Systemic Lupus Erythematosus (SLE)
    • Systemic Sclerosis
  • Diagnostics
  • Case Studies
    • ANCA-Associated Vasculitis
    • Behcet’s Syndrome
    • Crystalline Arthropathies
    • Giant Cell Arteritis
    • Henoch-Schönlein Purpura
    • IgG4-Related Disease
    • Juvenile Dermatomyositis
    • Juvenile Inflammatory Arthritis
    • Kawasaki Disease
    • Mixed Connective Tissue Disease
    • Polyarteritis Nodosa
    • Polymalgia Rheumatica
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sicca/Sjogren’s Disease
    • Spondyloarthritis
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
  • Meds
    • Treatment Guides
    • Addressing Patient Fears
    • Treatment Considerations
    • Major Categories of Rheumatology Medications
  • Resources
    • Vaccination Considerations – Pediatrics
    • Vaccination Considerations – Adults

Treatment Considerations

Home » Treatment Considerations
Treatment Considerations

Drug Toxicities

What are major side effect profiles that I should be aware of?

The following is not an inclusive list.

Neuro-Psychiatric

  • Aprimilast, Belimumab, and Broadlumab – worsening depression and suicidal ideation
  • Steroids can cause mood disorders
  • TNF-alpha inhibitors can cause demyelinating disorders

Ophthalmologic

  • Hydroxychloroquine – need to see ophthalmology annually while on this medication given retinal toxicity
  • Steroids – can cause glaucoma and cataracts

Cardiovascular/Thrombotic

  • Jak-Inhibitors have a black box warning for thrombosis and cardiovascular disease
  • IL-6 inhibitors can increase lipids
  • Steroids and NSAIDs can increase risk of CVD, HTN
  • Plaquenil can rarely cause cardiomyopathy

Pulmonology

  • MTX can causes interstitial pneumonitis
  • Orencia can worsen COPD exacerbations

Hepatic/Renal Toxicity

  • Hepatotoxic – methotrexate, leflunomide, NSAIDS, Imuran, IL-6 inhibitors
  • Several medications may affect the kidneys, or are renally dosed

Gastrointestinal

  • IL-6 inhibitors and Jak-inhibitors Gastrointestinal perforation
  • Steroids can cause PUD
  • NSAISD can use PUD and gastritis (COX-2 inhibitors have better tolerated GI side effects)
  • IL-17 inhibitors can worsen or cause inflammatory bowel disease

Infectious

  • Most of these medications need to be held when somebody has an acute infection or is on antibiotics. An exception to this rule is hydroxychloroquine which can be continued.
  • Consider these specific infections:
    • Hepatitis B reactivation – TNF-alpha inhibitors, rituximab
    • Latent tuberculosis reactivation – TNF-alpha inhibitors
    • Progressive multifocal leukoencephalopathy (PML) – rituximab
    • Herpes Zoster – belimumab, Jak Inhibitors
    • Pneumocystis pneumonia – steroids (consider PJP prophylaxis when indicated)
    • Meningococcemia – eculizimab

Hematology/Oncology

  • Cytopenia: Rituximab, methotrexate, sulfasalazine, leflunomide, mycophenolate, azathioprine, IL-1 inhibitors
  • Malignancy: methotrexate, azathioprine, mycophenolate, TNF-alpha inhibitors, cyclophosphamide

Endocrine

  • Steroids can cause hyperglycemia (diabetes), osteoporosis and adrenal insufficiency (consider Calcium/Vit D supplementation and screening DEXA)

Teratogenic

  • Cyclophosphamide, methotrexate, leflunomide, mycophenolate, thalidomide
View Guidelines for Pregnancy and Rheumatic Disease

Perioperative Concerns

Should you schedule elective surgeries for patients on rheumatology medications?

  • Hold most medications one dosing interval prior to surgery.
  • Hold for 2 weeks until wound healing.
  • Look at the guidelines for specific medications.

The ACR, together with the American Association of Hip and Knee Surgeons, have published a guideline on perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. 

View Guideline
Tami Bonnett-Admi2024-02-20T17:16:32+00:00

Treatment Fact Sheets

Visit ACR’s website to view information on some of the most common medications and therapies used to treat rheumatic disease, including how they work, common dosages, safety tips, possible side effects, and risks.

Fact sheets are downloadable/printable PDFs that you can provide to your patients, as well.
View Fact sheets

ACR Information

About ACR

ACR Contacts

Website Feedback

What do you think about the website? We would love to hear your feedback.

Provide Feedback

Authors

This product was funded by a medical grant from Pfizer. The content was written by a physician work group. See Authors.

© Copyright American College of Rheumatology 2026 | All rights reserved | See ACR Policies

Page load link
Go to Top